BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test sale cost 3200 AED
Biopsy Renal 3 Bottle Paraffin and EM Test sale cost 3980 AED Biopsy Renal 3 Bottle Paraffin and EM Test Cost 4,420 د.إ Original price was: 4,420 د.إ.3,980 د.إCurrent price is: 3,980 د.إ.
CLN6 Additional Family Members Test sale cost 2600 AED CLN6 Additional Family Members Test Cost 4,000 د.إ Original price was: 4,000 د.إ.2,600 د.إCurrent price is: 2,600 د.إ.
Sale!

BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test Cost

Original price was: 4,000 د.إ.Current price is: 3,200 د.إ.

-20%

The BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test is a specialized diagnostic procedure performed at DNA Labs UAE, aimed at detecting mutations within the kinase domain of the BCR-ABL1 gene. This gene is critically associated with chronic myeloid leukemia (CML) and some forms of acute lymphoblastic leukemia (ALL), where the presence of mutations can influence a patient’s response to targeted therapies, particularly tyrosine kinase inhibitors (TKIs). The test is essential for guiding treatment decisions, monitoring resistance, and predicting outcomes for patients with these hematologic malignancies.

Utilizing cutting-edge technology, the IRMA (Isotope Ratio Mass Analysis) technique provides a highly sensitive and specific analysis of the BCR-ABL1 gene, ensuring accurate detection of mutations that could impact the efficacy of treatment. The cost of the test at DNA Labs UAE is 3200 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. This test is a crucial tool in the personalized management of leukemia, allowing for tailored treatment approaches that can significantly improve patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test

Are you concerned about chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL)? The BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test offered by DNA Labs UAE can provide valuable insights into your condition. Read on to learn more about this test, its cost, symptoms, diagnosis, and other important details.

Test Name: BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test

Components:

  • EDTA Vacutainer (2ml)

Price: 3200.0 AED

Sample Condition:

Bone marrow / Peripheral blood (Transport immediately)

Report Delivery:

2-3 weeks

Method:

NGS (Next Generation Sequencing)

Test Type:

Genetics

Doctor:

General Physician

Test Department:

Pre Test Information

Pre Test Information:

The BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test can be done with a doctor’s prescription. Please note that prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test is a laboratory test used to detect mutations in the BCR-ABL1 gene. This gene is commonly found in chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL).

The BCR-ABL1 gene produces a protein called BCR-ABL1 kinase, which plays a crucial role in the development and progression of CML and ALL. Mutations in the BCR-ABL1 kinase domain can lead to resistance to targeted therapies such as tyrosine kinase inhibitors (TKIs).

The IRMA (Immune-Radiometric Assay) technique is used to analyze the BCR-ABL1 kinase domain mutations. This technique combines the use of antibodies and radioactive isotopes to detect and quantify specific mutations in the gene.

By analyzing the BCR-ABL1 kinase domain mutations, healthcare professionals can determine the presence of resistance mutations and tailor treatment options accordingly. This information helps in selecting the most appropriate TKI therapy for patients with CML or ALL, improving treatment outcomes and overall patient care.

Test Name BCR-ABL1 Kinase Domain Mutation Analysis IRMA Test
Components EDTA Vacutainer (2ml)
Price 3200.0 AED
Sample Condition Bone marrow \/ Peripheral blood (Transport immediately)
Report Delivery 2-3 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information BCR-ABL1 Kinase Domain Mutation Analysis IRMA] can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

BCR-ABL1 Kinase Domain Mutation Analysis [IRMA] is a laboratory test used to detect mutations in the BCR-ABL1 gene. BCR-ABL1 is a fusion gene that is commonly found in chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL).

The BCR-ABL1 gene produces a protein called BCR-ABL1 kinase, which plays a crucial role in the development and progression of CML and ALL. Mutations in the BCR-ABL1 kinase domain can lead to resistance to targeted therapies such as tyrosine kinase inhibitors (TKIs).

The IRMA (Immune-Radiometric Assay) technique is used to analyze the BCR-ABL1 kinase domain mutations. This technique combines the use of antibodies and radioactive isotopes to detect and quantify specific mutations in the gene.

By analyzing the BCR-ABL1 kinase domain mutations, healthcare professionals can determine the presence of resistance mutations and tailor treatment options accordingly. This information helps in selecting the most appropriate TKI therapy for patients with CML or ALL, improving treatment outcomes and overall patient care.

SKU: TEST-4692 Category:

Related products